SAFETY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANALYSIS OF LYMPHOCYTES IN THE LONG-TERM EXTENSION FINCH 4 STUDY

被引：1
|
作者：
Gottenberg, J. E. [1 ]
Burmester, G. R. [2 ]
Van Beneden, K. [3 ]
Watson, C. [4 ]
Seghers, I. [5 ]
Rajendran, V. [6 ]
Dagna, L. [7 ]
Buch, M. H. [8 ]
机构：
[1] Strasbourg Univ Hosp, Dept Rheumatol, Strasbourg, France
[2] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[3] Galapagos NV, Med Affairs, Mechelen, Belgium
[4] Galapagos Biotech Ltd, Med Affairs, Cambridge, England
[5] Galapagos NV, Biostatist, Mechelen, Belgium
[6] Galapagos NV, Clin Dev, Mechelen, Belgium
[7] IRCCS San Raffaele Hosp, Dept Internal Med, Unit Immunol Rheumatol Allergy & Rare Dis UnIRAR, Milan, Italy
[8] Univ Manchester, Sch Biol Sci, Ctr Musculoskeletal Res, Manchester, Lancs, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.888
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0513
引用
收藏
页码：512 / 513
页数：2
相关论文
共 50 条
  • [21] Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience
    Yocum, DE
    Furst, DE
    Bensen, WG
    Burch, FX
    Borton, MA
    Mengle-Gaw, LJ
    Schwartz, BD
    Wisememandle, W
    Mekki, QA
    RHEUMATOLOGY, 2004, 43 (08) : 992 - 999
  • [22] Safety of adalimumab in long-term treatment of patients with rheumatoid arthritis
    Schiff, M
    Burmester, GR
    Kent, J
    Pangan, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P203 - P203
  • [23] SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN INTERIM ANALYSIS UP TO 3.5 YEARS OF TREATMENT IN LONG-TERM EXTENSION STUDIES
    Tate, G.
    Scali, J.
    Monge, P.
    Kissel, K.
    Alecock, E.
    van Vollenhoven, R. F.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (03) : S43 - S44
  • [24] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Cohen, Stanley
    Pablos, Jose L.
    Pavelka, Karel
    Mueller, Gerard Anton
    Matsumoto, Alan
    Kivitz, Alan
    Wang, Hui
    Krishnan, Eswar
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
  • [25] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
    Stanley Cohen
    Jose L. Pablos
    Karel Pavelka
    Gerard Anton Müller
    Alan Matsumoto
    Alan Kivitz
    Hui Wang
    Eswar Krishnan
    Arthritis Research & Therapy, 21
  • [26] LONG TERM SAFETY AND EFFICACY OF FILGOTINIB IN A PHASE 2B OPEN LABEL EXTENSION STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS UP TO 144 WEEKS
    Alten, R.
    Westhovens, R.
    Kavanaugh, A.
    Genovese, M.
    Winthrop, K.
    Greenwald, M.
    Ponce, L.
    Enriquez, F.
    Stanislavchuk, M.
    Mazur, M.
    Spindler, A.
    Cseuz, R.
    Nikulenkova, N.
    Glowacka-Kulesz, M.
    Szombati, I.
    Dudek, A.
    Meuleners, L.
    Tasset, C.
    Harrison, P.
    Van der Aa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 267 - 267
  • [27] LONG-TERM SAFETY OF FILGOTINIB IN PATIENTS WITH PSA: WEEK 52 SAFETY DATA FROM A PHASE 2 OPENLABEL EXTENSION STUDY
    Coates, Laura
    Mease, Philip
    Gladman, Dafna
    Van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Guo, Ying
    Besuyen, Robin
    Helliwell, Philip
    RHEUMATOLOGY, 2020, 59
  • [28] Long-term Clinical Profile of Filgotinib in Patients with Rheumatoid Arthritis by Cardiovascular Risk Factors: A Post Hoc Subgroup Analysis
    Buch, Maya
    Gomez-Puerta, Jose A.
    Burmester, Gerd
    Combe, Bernard G.
    Rajendran, Vijay
    Stiers, Pieter-Jan
    Van Hoek, Paul
    Van Beneden, Katrien
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Aletaha, Daniel
    Westhovens, Rene
    Caporali, Roberto F.
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 875 - 877
  • [29] Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2)
    Takeuchi, Tsutomu
    Matsubara, Tsukasa
    Atsumi, Tatsuya
    Amano, Koichi
    Ishiguro, Naoki
    Sugiyama, Eiji
    Yamaoka, Kunihiro
    Genovese, Mark C.
    Kalunian, Kenneth
    Walker, David
    Gottenberg, Jacques-Eric
    de Vlam, Kurt
    Bartok, Beatrix
    Pechonkina, Alena
    Kondo, Akira
    Gao, Jie
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Tanaka, Yoshiya
    MODERN RHEUMATOLOGY, 2022, 32 (01) : 59 - 67
  • [30] A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis
    Huskisson, EC
    Ghozlan, R
    Kurthen, R
    Degner, FL
    Bluhmki, E
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 : 29 - 34
12345